Relationship between JAK2-V617F Gene Mutation in Peripheral Blood Mononuclear Cells and Thrombotic Events in Patients with Myeloproliferative Neoplasms
10.3969/j.issn.1671-7414.2017.02.040
- VernacularTitle:骨髓增殖性肿瘤患者外周血单个核细胞JAK2-V617F基因突变与血栓事件发生相关性分析
- Author:
Xiaobo GUO
;
Le YANG
;
Kangkang YAN
;
Ruili YANG
;
Jing LIN
- Keywords:
JAK2-V617 F;
myeloproliferative neoplasms (MPN);
gene
- From:
Journal of Modern Laboratory Medicine
2017;32(2):143-145
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the correlation between mutation in JAK2-V617F gene in peripheral blood mononuclear cells and thrombotic events in patients with myeloproliferative.Methods Investigation of thrombosis in 391 patients with MPN,using QRT-PCR to detect JAK2-V617F gene mutation in peripheral blood of patients.Result 105 cases of thrombotic events in 391 MPN patients (26.9%),84 cases of thrombotic events in 273 JAK2-V617F gene mutation positive patients (30.8 %),however,21 cases of thrombotic events in 118 J AK2-V617F gene mutation negative panents (17.8 %).The difference between the two groups was statistically significant (x2 =32.30,P<0.01).In the PV group,45 cases of thrombosis events in JAK2-V617F positive patients (29.2 %),6 cases of thrombosis events in JAK2-V617F negativepatients (42.9%),there was significant difference between the two groups (x2 =2.13,P>0.05).In the ET group,18 cases of thrombosis events in JAK2-V617F positive patients (32.2%),9 cases of thrombosis events in JAK2-V617F negative patients (15.8%),there was significant difference between the two groups (x2 =12.32,P<0.01).In the PMF group,21 cases of thrombosis events in JAK2-V617F posinve patients (33.3 %),6 cases of thrombosis events in JAK2-V617F negativepatients (12.8 %),there was significant difference between the two groups (x2 =14.32,P<0.01).Conclusion JAK2-V617F positive MPN patients were more susceptible to thrombotic events especially in patients with ET and PMF.